Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3849 Target Snapshot

Lanosterol 14-alpha demethylase · SINGLE PROTEIN · Homo sapiens

87Compounds
21Assays
12Approved Drugs
118.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q16850. Use UniProt Q16850 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q16850 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Lanosterol 14-alpha demethylase as ChEMBL target CHEMBL3849, mapped to UniProt Q16850. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Lanosterol 14-alpha demethylase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3849
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q16850
Lanosterol 14-alpha demethylase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Lanosterol 14-alpha demethylase is the right protein anchor across sources, using UniProt Q16850 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLanosterol 14-alpha demethylase
UniProt AccessionQ16850
Component TypeProtein
Sequence Length509 aa

Lanosterol 14-alpha demethylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Lanosterol 14-alpha demethylase, mapped to UniProt Q16850. Sequence length is 509 aa.

Mapped IDQ16850
Review nameLanosterol 14-alpha demethylase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

12
Approved
2
Phase III
Assay Mix

Activity Type Distribution

IC5084.0
KI4.0
KD30.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL305220 7.75 Ki 17.7 Preclinical
CHEMBL4461447 7.7 Kd 20.0 Preclinical
CHEMBL157101 7.61 Ki 24.5 Approved
CHEMBL808 7.3 IC50 50.0 Approved
CHEMBL4277680 7.22 Kd 60.0 Preclinical
CHEMBL4522116 7.05 Kd 90.0 Preclinical
CHEMBL3629567 7.05 Kd 90.0 Preclinical
CHEMBL157101 6.96 Kd 110.0 Approved
CHEMBL104 6.89 IC50 130.0 Approved
CHEMBL4439225 6.89 Kd 130.0 Preclinical
Distribution

pChEMBL Value Distribution

11
5.0
11
5.5
6
6.0
8
6.5
6
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ECONAZOLE
CHEMBL808
Approved 1982
KETOCONAZOLE
CHEMBL157101
Approved 1981
CLOTRIMAZOLE
CHEMBL104
Approved 1975
MICONAZOLE
CHEMBL91
Approved 1974
Assay Landscape

Assay Landscape

21
Total Assays
53
Tested Compounds
1
Assay Types
Binding — 21 assays, 53 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 6 5.2
assay format 7 21 5.8
cell-based format 2 24 5.4
microsome format 2 2 7.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine